The HIVE community supports Canadian dermatologists, allergists, immunologists and others with an interest in urticaria

Home
About HIVE
The Buzz
Whiteboard
Contact

Protected: Updates from the 30th EADV Congress: Dr. Ya Sophia Xu reviews guidance on selecting antihistamines for up-dosing patients with CSU, factors predicting response to treatment, and the impact of inducible urticarias in chronic urticaria [Video 12 min]

March 17, 2022June 19, 2022 ~ hivecanada

This content is password-protected. To view it, please enter the password below.

Password:

‹ PreviousUpdates from the 30th EADV Congress: Dr. Charles Lynde reviews guidance on how to recognize unmet needs of patients with CSU and translate key clinical trial evidence into practice (Video 10 min)

Next ›The Buzz, Issue #11 is now out! This month, we look at the phase 3 dupilumab study of pediatric asthma patients, and feature two new real-world studies of peanut immunotherapy, an investigation into reproducibility of anaphylactic symptoms sequences and the new CSACI position statement on transitioning to 0.50mg epinephrine autoinjectors.

Not a HIVE member?
Sign up here

The Health Innovation Virtual Engagement (HIVE) is a cross-specialty learning community for Canadian physicians, to support collaboration and enhance understanding of the condition of urticaria.

Some content on this site is password protected, available to HIVE members. You can find the password in your weekly Sosido HIVE email digest, sent every Wednesday.

Search for:

Website Powered by WordPress.com.

Subscribe Subscribed
- The HIVE Community
- Already have a WordPress.com account? Log in now.

Related